Literature DB >> 33583050

Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence".

Giovanni Paoletti1, Danilo Di Bona2, Derek K Chu3,4, Davide Firinu5, Enrico Heffler1, Ioana Agache6, Marek Jutel7, Ludger Klimek8, Oliver Pfaar9, Ralph Mösges10, Audrey DunnGalvin11, Jon Genuneit12,13, Hans Jürgen Hoffmann14, Giorgio Walter Canonica1.   

Abstract

BACKGROUND: Although there is a considerable body of knowledge about allergen immunotherapy (AIT), there is a lack of data on the reliability of real-world evidence (RWE) in AIT, and consequently, a lack of information on how AIT effectively works in real life.
METHODS: To address the current unmet need for an appraisal of the quality of RWE in AIT, the European Academy of Allergy and Clinical Immunology Methodology Committee recently initiated a systematic review of observational studies of AIT, which will use the RELEVANT tool and the Grading of Recommendations Assessment, Development and Evaluation approach (GRADE) to rate the quality of the evidence base as a whole. The next step will be to develop a broadly applicable, pragmatic "real-world" database using systematic data collection. Based on the current RWE base, and perspectives and recommendations of authorities and scientific societies, a hierarchy of RWE in AIT is proposed, which places pragmatic trials and registry data at the positions of highest level of evidence. KEY
RESULTS: There is a need to establish more AIT registries that collect data in a cohesive way, using standardized protocols.
CONCLUSIONS: This will provide an essential source of real-world data that can be easily shared, promoting evidence-based research and quality improvement in study design and clinical decision-making.
© 2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Entities:  

Keywords:  allergen immunotherapy; randomized controlled trial; real-world evidence; subcutaneous immunotherapy; sublingual immunotherapy

Mesh:

Year:  2021        PMID: 33583050     DOI: 10.1111/all.14773

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD).

Authors:  Oliver Pfaar; Tobias Ankermann; Matthias Augustin; Petra Bubel; Sebastian Böing; Randolf Brehler; Peter A Eng; Peter J Fischer; Michael Gerstlauer; Eckard Hamelmann; Thilo Jakob; Jörg Kleine-Tebbe; Matthias Volkmar Kopp; Susanne Lau; Norbert Mülleneisen; Christoph Müller; Katja Nemat; Wolfgang Pfützner; Joachim Saloga; Klaus Strömer; Peter Schmid-Grendelmeier; Antje Schuster; Gunter Johannes Sturm; Christian Taube; Zsolt Szépfalusi; Christian Vogelberg; Martin Wagenmann; Wolfgang Wehrmann; Thomas Werfel; Stefan Wöhrl; Margitta Worm; Bettina Wedi; Susanne Kaul; Vera Mahler; Anja Schwalfenberg
Journal:  Allergol Select       Date:  2022-09-06

2.  Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.

Authors:  Benedikt Fritzsching; Marco Contoli; Celeste Porsbjerg; Sarah Buchs; Julie Rask Larsen; Lisa Elliott; Mercedes Romano Rodriguez; Nick Freemantle
Journal:  Lancet Reg Health Eur       Date:  2021-11-30

3.  5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen.

Authors:  Sheryl A van Nunen; Melanie B Burk; Pamela K Burton; Geoffrey Ford; Richard J Harvey; Alexander Lozynsky; Elizabeth Pickford; Janet S Rimmer; Joanne Smart; Michael F Sutherland; Francis Thien; Heinrich C Weber; Harry Zehnwirth; Ed Newbigin; Constance H Katelaris
Journal:  World Allergy Organ J       Date:  2022-02-23       Impact factor: 4.084

4.  Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model.

Authors:  Bernardo Sousa-Pinto; Luís Filipe Azevedo; Ana Sá-Sousa; Rafael José Vieira; Rita Amaral; Ludger Klimek; Wienczyslawa Czarlewski; Josep M Anto; Anna Bedbrook; Violeta Kvedariene; Maria Teresa Ventura; Ignacio J Ansotegui; Karl-Christian Bergmann; Luisa Brussino; G Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Thomas Casale; Lorenzo Cecchi; Tomás Chivato; Derek K Chu; Cemal Cingi; Elisio M Costa; Alvaro A Cruz; Giulia De Feo; Philippe Devillier; Wytske J Fokkens; Mina Gaga; Bilun Gemicioğlu; Tari Haahtela; Juan Carlos Ivancevich; Zhanat Ispayeva; Marek Jutel; Piotr Kuna; Igor Kaidashev; Helga Kraxner; Désirée E Larenas-Linnemann; Daniel Laune; Brian Lipworth; Renaud Louis; Michaël Makris; Riccardo Monti; Mario Morais-Almeida; Ralph Mösges; Joaquim Mullol; Mikaëla Odemyr; Yoshitaka Okamoto; Nikolaos G Papadopoulos; Vincenzo Patella; Nhân Pham-Thi; Frederico S Regateiro; Sietze Reitsma; Philip W Rouadi; Boleslaw Samolinski; Milan Sova; Ana Todo-Bom; Luis Taborda-Barata; Peter Valentin Tomazic; Sanna Toppila-Salmi; Joaquin Sastre; Ioanna Tsiligianni; Arunas Valiulis; Dana Wallace; Susan Waserman; Arzu Yorgancioglu; Mihaela Zidarn; Torsten Zuberbier; João Almeida Fonseca; Jean Bousquet; Oliver Pfaar
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

5.  Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis.

Authors:  Cristiano Caruso; Paolo Cameli; Elena Altieri; Maria Aliani; Pietro Bracciale; Luisa Brussino; Maria Filomena Caiaffa; Giorgio Walter Canonica; Stefano Centanni; Maria D'Amato; Stefano Del Giacco; Fausto De Michele; Elide Anna Pastorello; Girolamo Pelaia; Paola Rogliani; Micaela Romagnoli; Pietro Schino; Marco Caminati; Alessandra Vultaggio; Alessandro Zullo; Sara Rizzoli; Silvia Boarino; Gianfranco Vitiello; Francesco Menzella; Fabiano Di Marco
Journal:  Front Med (Lausanne)       Date:  2022-09-02

Review 6.  Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology - ASBAI.

Authors:  Fernando Monteiro Aarestrup; Ernesto Akio Taketomi; Clóvis Eduardo Santos Galvão; Elaine Gagete; Anna Caroline Nóbrega Machado Arruda; Gil Bardini Alves; Geórgia Véras de Araújo Gueiros Lira; Marcos Reis Gonçalves; Mariana Graça Couto Miziara; Sidney Souteban Maranhão Casado; Simone Valladão Curi; Veridiana Aun Rufino Pereira; Valéria Sales; Dirceu Solé; Norma de Paula Motta Rubini; Emanuel Savio Cavalcanti Sarinho
Journal:  World Allergy Organ J       Date:  2022-09-24       Impact factor: 5.516

7.  Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis.

Authors:  Danilo Di Bona; Giovanni Paoletti; Derek K Chu; Jack Pepys; Luigi Macchia; Enrico Heffler; Giorgio Walter Canonica
Journal:  Clin Transl Allergy       Date:  2021-06-14       Impact factor: 5.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.